On December 2, the Management Committee of Beijing Economic and Technological Development Zone and Sanofi officially signed a memorandum of cooperation. Sanofi will invest about 1 billion euros to build a new insulin production base in Beijing Yizhuang, improve the local "end-to-end" production and manufacturing capacity of insulin, and focus on serving the insulin demand of local diabetes patients.